EMTRICITABINE

EMTRICITABINE was reported 45432 times

EMTRICITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 21-HYDROXYLASE DEFICIENCY 5 0.5000
1 GLUCOCORTICOIDS INCREASED 9 0.4500
2 ULTRASOUND ANTENATAL SCREEN 42 0.4375
3 ANAL CHLAMYDIA INFECTION 5 0.4167
4 CSF HIV ESCAPE SYNDROME 55 0.3986
5 SPINOCEREBELLAR DISORDER 18 0.3830
6 HYPERANDROGENISM 29 0.3085
7 CRITICAL ILLNESS MYOPATHY 7 0.2917
8 CSF VIRUS IDENTIFIED 17 0.2429
9 ENLARGED CLITORIS 32 0.1939
10 CSF HIV VIRUS IDENTIFIED 4 0.1739
11 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 17 0.1532
12 CONGENITAL TRICUSPID VALVE STENOSIS 4 0.1481
13 FLOPPY EYELID SYNDROME 5 0.1429
14 BLOOD HIV RNA 7 0.1346
15 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 40 0.1194
16 SEROCONVERSION TEST POSITIVE 6 0.1132
17 HIV WASTING SYNDROME 4 0.1111
18 AIDS DEMENTIA COMPLEX 6 0.0984
19 PSYCHIATRIC DECOMPENSATION 183 0.0936
20 PULMONARY HILAR ENLARGEMENT 5 0.0893
21 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 5 0.0847
22 BLOOD HIV RNA INCREASED 153 0.0843
23 CONGENITAL GENITAL MALFORMATION FEMALE 4 0.0816
24 TRISOMY 18 31 0.0814
25 ACUTE HIV INFECTION 20 0.0810
26 HIV ASSOCIATED NEPHROPATHY 4 0.0784
27 VIROLOGIC FAILURE 407 0.0756
28 HYDROPS FOETALIS 45 0.0734
29 HEREDITARY OPTIC ATROPHY 5 0.0714
30 SECONDARY SYPHILIS 7 0.0707
31 DIABETES WITH HYPEROSMOLARITY 4 0.0690
32 RENAL TUBULAR DYSFUNCTION 38 0.0673
33 ADRENOGENITAL SYNDROME 9 0.0667
34 ECTOPIC KIDNEY 6 0.0632
35 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 300 0.0601
36 MITOCHONDRIAL MYOPATHY 13 0.0596
37 MENINGOCELE 9 0.0573
38 ENCEPHALOCELE 14 0.0562
39 FAT REDISTRIBUTION 13 0.0560
40 PSYCHOMOTOR SKILLS IMPAIRED 139 0.0530
41 GENOTYPE DRUG RESISTANCE TEST POSITIVE 53 0.0516
42 VIRAL MUTATION IDENTIFIED 176 0.0477
43 DEPRESSION SUICIDAL 155 0.0447
44 HIV VIRAEMIA 9 0.0429
45 HYPOPLASTIC RIGHT HEART SYNDROME 6 0.0426
46 DEPRESSIVE SYMPTOM 144 0.0408
47 PULMONARY VENOUS THROMBOSIS 6 0.0400
48 INTERCAPILLARY GLOMERULOSCLEROSIS 4 0.0381
49 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 41 0.0373
50 GASTROINTESTINAL MUCORMYCOSIS 6 0.0359
51 TEARFULNESS 154 0.0358
52 CONGENITAL HYDROCEPHALUS 18 0.0355
53 IMMUNE RECONSTITUTION SYNDROME 45 0.0349
54 SPINA BIFIDA 72 0.0345
55 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 9 0.0324
56 FANCONI SYNDROME ACQUIRED 55 0.0313
57 MELANODERMA 6 0.0312
58 NEURAL TUBE DEFECT 22 0.0303
59 FANCONI SYNDROME 42 0.0297
60 DRUG RESISTANCE MUTATION 5 0.0281
61 CLEFT LIP AND PALATE 31 0.0277
62 POLYDACTYLY 32 0.0276
63 HIGH-GRADE B-CELL LYMPHOMA 5 0.0267
64 CONGENITAL TRICUSPID VALVE ATRESIA 4 0.0267
65 ANOGENITAL DYSPLASIA 4 0.0267
66 PULMONARY HYPOPLASIA 21 0.0266
67 PORTAL HYPERTENSIVE GASTROPATHY 15 0.0266
68 CONGENITAL HYDRONEPHROSIS 19 0.0266
69 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 9 0.0251
70 ACQUIRED IMMUNODEFICIENCY SYNDROME 13 0.0250
71 BONE DEMINERALISATION 26 0.0246
72 PATHOGEN RESISTANCE 220 0.0241
73 EXTRAPULMONARY TUBERCULOSIS 7 0.0237
74 HYDROCELE 25 0.0235
75 HAEMOGLOBINAEMIA 4 0.0234
76 PORTAL FIBROSIS 5 0.0234
77 GINGIVITIS ULCERATIVE 5 0.0233
78 ANENCEPHALY 13 0.0230
79 CENTRAL OBESITY 17 0.0230
80 LIPODYSTROPHY ACQUIRED 48 0.0226
81 TOXIC CARDIOMYOPATHY 5 0.0223
82 IIIRD NERVE PARESIS 4 0.0220
83 CD4 LYMPHOCYTES INCREASED 5 0.0215
84 VIRAEMIA 28 0.0202
85 CUSHING'S SYNDROME 14 0.0201
86 STILLBIRTH 97 0.0201
87 PSYCHOMOTOR RETARDATION 55 0.0196
88 HEPATITIS B DNA INCREASED 13 0.0193
89 PORPHYRIA NON-ACUTE 8 0.0184
90 CD4 LYMPHOCYTES DECREASED 39 0.0182
91 MENINGITIS CRYPTOCOCCAL 31 0.0177
92 HEPATITIS C RNA INCREASED 6 0.0175
93 GENE MUTATION 34 0.0172
94 FIBROUS HISTIOCYTOMA 6 0.0171
95 GLYCOSURIA 23 0.0170
96 DRUG RESISTANCE 437 0.0170
97 GENITAL DISCHARGE 4 0.0167
98 ADRENAL SUPPRESSION 14 0.0166
99 HAEMORRHOIDS THROMBOSED 5 0.0166
100 BLOOD CORTICOTROPHIN DECREASED 8 0.0164
101 CEREBRAL TOXOPLASMOSIS 15 0.0161
102 HIV INFECTION 48 0.0159
103 CYTOMEGALOVIRUS CHORIORETINITIS 30 0.0154
104 HISTOPLASMOSIS 27 0.0152
105 VIRAL LOAD INCREASED 59 0.0152
106 HIV TEST POSITIVE 10 0.0151
107 CENTRAL NERVOUS SYSTEM INFLAMMATION 5 0.0151
108 WHITE MATTER LESION 19 0.0150
109 MENINGOMYELOCELE 9 0.0150
110 OSTEOMALACIA 23 0.0149
111 RETINAL TOXICITY 15 0.0146
112 DEATH NEONATAL 20 0.0144
113 RENAL TUBULAR DISORDER 40 0.0142
114 HYPERFERRITINAEMIA 6 0.0139
115 SUPERINFECTION BACTERIAL 11 0.0139
116 ERYTHEMA ANNULARE 4 0.0138
117 SYPHILIS 10 0.0138
118 LUNG TRANSPLANT REJECTION 9 0.0136
119 VANISHING BILE DUCT SYNDROME 15 0.0135
120 RENAL DYSPLASIA 5 0.0129
121 SKIN TURGOR DECREASED 5 0.0129
122 LIPOHYPERTROPHY 8 0.0129
123 HEMIPARAESTHESIA 5 0.0128
124 PORTAL HYPERTENSION 39 0.0126
125 MENINGITIS TUBERCULOUS 7 0.0125
126 BLOOD CORTISOL DECREASED 8 0.0125
127 BREAST HAEMORRHAGE 4 0.0121
128 CRYSTAL NEPHROPATHY 7 0.0118
129 GIARDIASIS 4 0.0117
130 VENTRICULAR SEPTAL DEFECT 64 0.0112
131 TOXOPLASMOSIS 12 0.0111
132 BRAIN HERNIATION 33 0.0110
133 MITOCHONDRIAL TOXICITY 9 0.0110
134 DRUG-DISEASE INTERACTION 8 0.0109
135 CHRONIC HEPATITIS C 4 0.0101
136 MALARIA 7 0.0099
137 DYSLIPIDAEMIA 50 0.0098
138 MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.0097
139 SYNDACTYLY 8 0.0096
140 DRUG LEVEL CHANGED 6 0.0095
141 FOLATE DEFICIENCY 11 0.0095
142 CEREBELLAR ATAXIA 9 0.0094
143 NODULAR REGENERATIVE HYPERPLASIA 6 0.0093
144 MULTIPLE-DRUG RESISTANCE 29 0.0093
145 CUSHINGOID 30 0.0093
146 PARANOIA 161 0.0093
147 MOLLUSCUM CONTAGIOSUM 5 0.0093
148 ENCEPHALITIS CYTOMEGALOVIRUS 4 0.0091
149 NEPHROPATHY TOXIC 102 0.0091
150 ANOGENITAL WARTS 8 0.0090
151 FOETAL EXPOSURE DURING DELIVERY 6 0.0088
152 INFECTION REACTIVATION 10 0.0087
153 PRURIGO 8 0.0087
154 ENTERAL NUTRITION 5 0.0086
155 PLEOCYTOSIS 5 0.0086
156 LIMB REDUCTION DEFECT 5 0.0086
157 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
158 PARADOXICAL DRUG REACTION 31 0.0084
159 GASTROSCHISIS 4 0.0084
160 OSTEOPOROTIC FRACTURE 16 0.0084
161 VISCERAL LEISHMANIASIS 6 0.0083
162 HODGKIN'S DISEASE 6 0.0083
163 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 4 0.0082
164 DISSEMINATED TUBERCULOSIS 21 0.0082
165 ANGIOCENTRIC LYMPHOMA 4 0.0081
166 BLOOD BILIRUBIN DECREASED 5 0.0081
167 HYPERSPLENISM 4 0.0081
168 SKIN STRIAE 12 0.0081
169 PULMONARY TUBERCULOSIS 34 0.0080
170 CONGENITAL ANOMALY 61 0.0079
171 CYTOMEGALOVIRUS COLITIS 18 0.0078
172 GENITAL ULCERATION 6 0.0078
173 ANHEDONIA 204 0.0078
174 ANAEMIA OF CHRONIC DISEASE 7 0.0077
175 FOETAL EXPOSURE DURING PREGNANCY 622 0.0076
176 OESOPHAGEAL CANDIDIASIS 30 0.0075
177 BURSITIS INFECTIVE 4 0.0074
178 ATRIAL SEPTAL DEFECT 61 0.0073
179 ECONOMIC PROBLEM 110 0.0073
180 SMALL FOR DATES BABY 36 0.0072
181 CONGENITAL CARDIOVASCULAR ANOMALY 6 0.0072
182 LYMPHOCYTIC INFILTRATION 7 0.0069
183 CARBON DIOXIDE DECREASED 8 0.0069
184 CHYLOTHORAX 5 0.0069
185 HYPERBILIRUBINAEMIA NEONATAL 4 0.0069
186 INTRA-UTERINE DEATH 11 0.0068
187 GENERALISED ANXIETY DISORDER 10 0.0068
188 HYPOPHOSPHATAEMIA 50 0.0068
189 COCCIDIOIDOMYCOSIS 8 0.0067
190 SECONDARY ADRENOCORTICAL INSUFFICIENCY 10 0.0066
191 ENCEPHALITIS VIRAL 8 0.0066
192 HEART DISEASE CONGENITAL 23 0.0065
193 HEPATOBILIARY DISEASE 4 0.0064
194 CRYPTORCHISM 7 0.0062
195 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
196 STRONGYLOIDIASIS 10 0.0062
197 ACQUIRED GENE MUTATION 8 0.0061
198 AUTOIMMUNE HEPATITIS 42 0.0060
199 AMAUROSIS 5 0.0059
200 AUTONOMIC NEUROPATHY 6 0.0059
201 PSEUDOMONAL BACTERAEMIA 5 0.0059
202 RENAL TUBULAR NECROSIS 57 0.0058
203 ENDOCRINE OPHTHALMOPATHY 5 0.0058
204 ABORTION INDUCED 54 0.0057
205 OLIGOHYDRAMNIOS 19 0.0057
206 ASTERIXIS 6 0.0056
207 CACHEXIA 29 0.0056
208 DRUG LEVEL FLUCTUATING 5 0.0056
209 PSYCHOTIC DISORDER 166 0.0056
210 CYTOMEGALOVIRUS TEST POSITIVE 10 0.0056
211 HYPERBILIRUBINAEMIA 57 0.0055
212 HEPATITIS B 33 0.0055
213 PREMATURE DELIVERY 87 0.0055
214 PNEUMONIA PNEUMOCOCCAL 8 0.0054
215 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
216 PREMATURE RUPTURE OF MEMBRANES 13 0.0054
217 OBLITERATIVE BRONCHIOLITIS 7 0.0053
218 CEREBRAL PALSY 5 0.0053
219 OSTEOPENIA 79 0.0052
220 INHIBITORY DRUG INTERACTION 8 0.0051
221 RENAL TUBULAR ACIDOSIS 11 0.0050
222 RENAL TUBULAR INJURY 6 0.0049
223 VASCULAR STENT THROMBOSIS 10 0.0049
224 CRYPTOCOCCOSIS 8 0.0049
225 MENINGITIS BACTERIAL 7 0.0049
226 CSF PROTEIN INCREASED 4 0.0048
227 HYPERPARATHYROIDISM SECONDARY 12 0.0048
228 TRISOMY 21 6 0.0048
229 LOW BIRTH WEIGHT BABY 37 0.0047
230 HYPERTRIGLYCERIDAEMIA 27 0.0046
231 NASAL SEPTUM DEVIATION 9 0.0046
232 HILAR LYMPHADENOPATHY 4 0.0045
233 RIGHT VENTRICULAR DYSFUNCTION 5 0.0045
234 PREMATURE BABY 134 0.0044
235 FOETAL GROWTH RESTRICTION 27 0.0044
236 HEPATIC CYTOLYSIS 56 0.0044
237 TOTAL LUNG CAPACITY DECREASED 7 0.0044
238 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
239 END STAGE RENAL DISEASE 79 0.0043
240 FOETAL HEART RATE ABNORMAL 4 0.0043
241 LIVE BIRTH 36 0.0043
242 FOETAL DEATH 22 0.0042
243 NEONATAL RESPIRATORY DISTRESS SYNDROME 15 0.0042
244 GLOMERULAR FILTRATION RATE ABNORMAL 6 0.0042
245 LIPOATROPHY 4 0.0042
246 ARNOLD-CHIARI MALFORMATION 4 0.0042
247 DRUG INTERACTION 663 0.0042
248 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 5 0.0042
249 OESOPHAGEAL VARICES HAEMORRHAGE 9 0.0041
250 BLOOD PHOSPHORUS DECREASED 15 0.0041
251 VARICES OESOPHAGEAL 12 0.0040
252 NEPHRITIS INTERSTITIAL 5 0.0040
253 TRANSPLANT DYSFUNCTION 7 0.0039
254 NEUROLOGICAL SYMPTOM 22 0.0038
255 OPHTHALMOPLEGIA 6 0.0038
256 ENTEROCOCCAL BACTERAEMIA 4 0.0038
257 EXPOSURE DURING PREGNANCY 229 0.0037
258 FOETAL MALFORMATION 4 0.0037
259 MENINGITIS VIRAL 5 0.0036
260 ATROPHY 7 0.0036
261 SALMONELLOSIS 6 0.0036
262 ACUTE LYMPHOCYTIC LEUKAEMIA 10 0.0035
263 LIGAMENT INJURY 4 0.0035
264 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 29 0.0035
265 HEPATOSPLENOMEGALY 9 0.0035
266 BLOOD AMYLASE INCREASED 6 0.0035
267 MUCORMYCOSIS 9 0.0035
268 OSTEOPOROSIS 141 0.0034
269 QUADRIPLEGIA 7 0.0034
270 HYPERPARATHYROIDISM 7 0.0034
271 ADRENAL INSUFFICIENCY 41 0.0034
272 HEPATITIS FULMINANT 10 0.0034
273 HYPERLACTACIDAEMIA 9 0.0034
274 CYTOLYTIC HEPATITIS 11 0.0033
275 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
276 PNEUMOPERITONEUM 6 0.0032
277 OPPORTUNISTIC INFECTION 6 0.0032
278 FRACTURED SACRUM 4 0.0032
279 CEREBELLAR SYNDROME 7 0.0032
280 PERIPHERAL VENOUS DISEASE 13 0.0032
281 HYPERCOAGULATION 6 0.0031
282 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
283 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
284 IATROGENIC INJURY 4 0.0031
285 TREATMENT NONCOMPLIANCE 168 0.0031
286 ABORTION SPONTANEOUS 123 0.0031
287 HEPATOMEGALY 30 0.0030
288 RENAL TRANSPLANT 11 0.0030
289 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
290 DIPLEGIA 6 0.0030
291 QUADRIPARESIS 5 0.0030
292 CAESAREAN SECTION 35 0.0030
293 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0030
294 LIPIDS INCREASED 6 0.0030
295 SPLENOMEGALY 34 0.0029
296 KIDNEY FIBROSIS 5 0.0029
297 CONGESTIVE CARDIOMYOPATHY 12 0.0029
298 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
299 FACIAL PARESIS 10 0.0028
300 HYPERNATRAEMIA 14 0.0028
301 POLYDIPSIA 11 0.0028
302 BONE DENSITY DECREASED 87 0.0028
303 OCULAR ICTERUS 12 0.0028
304 STRABISMUS 8 0.0027
305 PROTEINURIA 51 0.0027
306 PREGNANCY ON ORAL CONTRACEPTIVE 7 0.0027
307 ORAL CANDIDIASIS 35 0.0027
308 HEPATIC NECROSIS 10 0.0027
309 BLOOD BICARBONATE DECREASED 5 0.0026
310 STEATORRHOEA 7 0.0026
311 NEPHROGENIC ANAEMIA 12 0.0026
312 BILIRUBIN CONJUGATED INCREASED 6 0.0026
313 PREGNANCY WITH IMPLANT CONTRACEPTIVE 12 0.0026
314 PRE-ECLAMPSIA 12 0.0025
315 GLOMERULAR FILTRATION RATE DECREASED 31 0.0025
316 HEPATITIS B REACTIVATION 8 0.0025
317 GESTATIONAL DIABETES 12 0.0025
318 NEUROTOXICITY 44 0.0025
319 DIABETES INSIPIDUS 6 0.0025
320 POLYCYTHAEMIA 5 0.0024
321 HYDRONEPHROSIS 18 0.0024
322 HEPATITIS C 29 0.0024
323 HYDROCEPHALUS 13 0.0024
324 CHRONIC KIDNEY DISEASE 176 0.0023
325 ECTOPIC PREGNANCY 7 0.0023
326 FIBROSIS 7 0.0023
327 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
328 AZOTAEMIA 9 0.0023
329 NEPHROPATHY 21 0.0022
330 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
331 DRUG LEVEL INCREASED 37 0.0022
332 RENAL COLIC 5 0.0022
333 LIP BLISTER 6 0.0022
334 GLUCOSE TOLERANCE IMPAIRED 13 0.0022
335 LACTIC ACIDOSIS 71 0.0022
336 LYMPHOEDEMA 15 0.0022
337 ENCEPHALITIS 15 0.0022
338 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0022
339 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 11 0.0021
340 MATERNAL EXPOSURE DURING PREGNANCY 190 0.0021
341 BLOOD CREATININE INCREASED 139 0.0021
342 ACUTE HEPATIC FAILURE 29 0.0021
343 URINARY HESITATION 5 0.0021
344 RENAL IMPAIRMENT 176 0.0021
345 BLOOD LACTIC ACID INCREASED 11 0.0021
346 QUALITY OF LIFE DECREASED 28 0.0021
347 SUICIDAL IDEATION 191 0.0021
348 HERPES VIRUS INFECTION 12 0.0021
349 HEPATOTOXICITY 46 0.0021
350 DRUG LEVEL DECREASED 21 0.0021
351 TREATMENT FAILURE 170 0.0020
352 HEPATIC FIBROSIS 7 0.0020
353 VENOUS THROMBOSIS 8 0.0020
354 HAEMODIALYSIS 17 0.0020
355 HYPERPHAGIA 8 0.0020
356 TRANSPLANT REJECTION 16 0.0020
357 HEPATITIS CHOLESTATIC 12 0.0020
358 CARDIAC DISCOMFORT 4 0.0020
359 EMOTIONAL DISTRESS 239 0.0020
360 ACIDOSIS 15 0.0020
361 MENINGITIS 13 0.0019
362 DECREASED ACTIVITY 21 0.0019
363 CHEST INJURY 4 0.0019
364 HEPATITIS TOXIC 5 0.0019
365 BLOOD PROLACTIN INCREASED 9 0.0019
366 SOCIAL AVOIDANT BEHAVIOUR 11 0.0019
367 HAEMOLYTIC ANAEMIA 17 0.0019
368 SARCOIDOSIS 9 0.0019
369 NYSTAGMUS 10 0.0019
370 PERIPHERAL SENSORY NEUROPATHY 11 0.0019
371 MALNUTRITION 21 0.0019
372 ANAEMIA MACROCYTIC 4 0.0019
373 EYELID PTOSIS 19 0.0019
374 ALCOHOLISM 8 0.0019
375 ENTEROCOCCAL INFECTION 9 0.0019
376 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
377 POLYURIA 15 0.0018
378 ASPERGILLUS INFECTION 12 0.0018
379 MULTIPLE FRACTURES 30 0.0018
380 TYPE IV HYPERSENSITIVITY REACTION 5 0.0018
381 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
382 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
383 ASPARTATE AMINOTRANSFERASE INCREASED 96 0.0018
384 FAECES PALE 4 0.0018
385 DERMATITIS EXFOLIATIVE 9 0.0018
386 METABOLIC ACIDOSIS 57 0.0018
387 GASTROENTERITIS 26 0.0018
388 SKIN ODOUR ABNORMAL 7 0.0018
389 STATUS EPILEPTICUS 20 0.0018
390 PREMATURE LABOUR 10 0.0018
391 DISTRIBUTIVE SHOCK 4 0.0018
392 APLASIA PURE RED CELL 6 0.0017
393 PNEUMONIA BACTERIAL 16 0.0017
394 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
395 RENAL FAILURE ACUTE 73 0.0017
396 ALANINE AMINOTRANSFERASE INCREASED 105 0.0017
397 LIPASE INCREASED 13 0.0017
398 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
399 MACULOPATHY 6 0.0017
400 CYTOMEGALOVIRUS INFECTION 28 0.0017
401 PANCYTOPENIA 94 0.0017
402 HEPATITIS 43 0.0017
403 NEUTROPENIC SEPSIS 12 0.0017
404 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
405 TYPE 1 DIABETES MELLITUS 10 0.0017
406 LIVER TRANSPLANT 6 0.0016
407 PREGNANCY 33 0.0016
408 ACUTE PSYCHOSIS 4 0.0016
409 PANCREATITIS ACUTE 36 0.0016
410 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 14 0.0016
411 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 76 0.0016
412 ILEUS PARALYTIC 7 0.0016
413 RENAL FAILURE 205 0.0015
414 LIVER ABSCESS 5 0.0015
415 MALABSORPTION 8 0.0015
416 SKIN LESION 42 0.0015
417 DRUG EXPOSURE DURING PREGNANCY 52 0.0015
418 ANXIETY 432 0.0015
419 BRAIN OEDEMA 19 0.0015
420 MULTI-ORGAN FAILURE 26 0.0015
421 AREFLEXIA 4 0.0015
422 CANDIDIASIS 6 0.0015
423 POTENTIATING DRUG INTERACTION 5 0.0015
424 ARTERIOSCLEROSIS 14 0.0015
425 HAEMATOTOXICITY 14 0.0015
426 BLOOD PHOSPHORUS INCREASED 4 0.0015
427 HYPERCALCAEMIA 18 0.0015
428 BLOOD BILIRUBIN INCREASED 39 0.0014
429 LYMPHADENOPATHY 51 0.0014
430 LARGE INTESTINE PERFORATION 10 0.0014
431 RASH MACULO-PAPULAR 32 0.0014
432 LUNG CONSOLIDATION 4 0.0014
433 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
434 CHOLESTASIS 27 0.0014
435 OSTEONECROSIS 46 0.0014
436 ACUTE KIDNEY INJURY 213 0.0014
437 ACUTE MYOCARDIAL INFARCTION 41 0.0014
438 MONOCYTE COUNT INCREASED 5 0.0014
439 LUMBAR SPINAL STENOSIS 4 0.0014
440 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0014
441 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
442 CEREBRAL DISORDER 10 0.0014
443 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
444 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
445 NERVOUS SYSTEM DISORDER 42 0.0013
446 PARKINSONISM 13 0.0013
447 BONE MARROW FAILURE 27 0.0013
448 ACUTE CORONARY SYNDROME 11 0.0013
449 LOSS OF EMPLOYMENT 4 0.0013
450 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
451 CLAVICLE FRACTURE 5 0.0013
452 JAUNDICE 35 0.0013
453 OLIGURIA 8 0.0013
454 HEPATIC ENCEPHALOPATHY 12 0.0013
455 PSEUDOMONAS INFECTION 11 0.0013
456 HAND FRACTURE 9 0.0013
457 FOOT FRACTURE 24 0.0013
458 NEOPLASM PROGRESSION 44 0.0013
459 BLOOD ALBUMIN DECREASED 10 0.0013
460 STEVENS-JOHNSON SYNDROME 28 0.0013
461 HYPOVOLAEMIC SHOCK 6 0.0013
462 HYPERCHOLESTEROLAEMIA 12 0.0012
463 HERPES SIMPLEX 8 0.0012
464 MYOSITIS 11 0.0012
465 DEAFNESS NEUROSENSORY 4 0.0012
466 SOCIAL PROBLEM 5 0.0012
467 IMMUNODEFICIENCY 18 0.0012
468 EYELID OEDEMA 14 0.0012
469 BONE LOSS 18 0.0012
470 BLOOD UREA INCREASED 20 0.0012
471 TOXIC SKIN ERUPTION 12 0.0012
472 RHABDOMYOLYSIS 49 0.0012
473 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
474 PROTHROMBIN TIME PROLONGED 7 0.0012
475 TRANSAMINASES INCREASED 26 0.0012
476 RIB FRACTURE 24 0.0012
477 HEPATIC FAILURE 35 0.0012
478 MYOPATHY 10 0.0012
479 SPINAL FRACTURE 23 0.0011
480 BRONCHIOLITIS 4 0.0011
481 MULTIPLE ORGAN DYSFUNCTION SYNDROME 32 0.0011
482 RESPIRATORY RATE INCREASED 10 0.0011
483 CORONARY ARTERY DISEASE 34 0.0011
484 ASCITES 33 0.0011
485 CONJUNCTIVAL HYPERAEMIA 4 0.0011
486 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
487 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
488 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
489 COAGULOPATHY 18 0.0011
490 RENAL FUNCTION TEST ABNORMAL 5 0.0011
491 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
492 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
493 HEPATOCELLULAR CARCINOMA 8 0.0011
494 EXERCISE TOLERANCE DECREASED 6 0.0010
495 PERICARDIAL EFFUSION 24 0.0010
496 DEPRESSION 235 0.0010
497 HYPOALBUMINAEMIA 8 0.0010
498 VITAMIN D DEFICIENCY 10 0.0010
499 TOOTH LOSS 21 0.0010
500 HEPATIC CIRRHOSIS 19 0.0010
501 CEREBRAL ATROPHY 4 0.0010
502 PROTEIN URINE PRESENT 5 0.0010
503 HEPATIC ENZYME ABNORMAL 5 0.0010
504 GOITRE 4 0.0010
505 FEMORAL NECK FRACTURE 5 0.0010
506 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
507 SPINAL COMPRESSION FRACTURE 8 0.0010
508 HEPATIC STEATOSIS 18 0.0010
509 ANAEMIA 183 0.0010
510 DRUG-INDUCED LIVER INJURY 30 0.0010
511 INTENTIONAL PRODUCT USE ISSUE 83 0.0009
512 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
513 RENAL PAIN 10 0.0009
514 BUNDLE BRANCH BLOCK LEFT 4 0.0009
515 HYPOGAMMAGLOBULINAEMIA 6 0.0009
516 MELANOCYTIC NAEVUS 4 0.0009
517 TUMOUR LYSIS SYNDROME 8 0.0009
518 LUNG INFILTRATION 8 0.0009
519 ANKLE FRACTURE 14 0.0009
520 FRACTURE 17 0.0009
521 CARDIOTOXICITY 8 0.0009
522 FACE OEDEMA 15 0.0009
523 TACHYPNOEA 12 0.0009
524 CHOLECYSTITIS ACUTE 5 0.0009
525 CIRCULATORY COLLAPSE 15 0.0009
526 OESOPHAGEAL CARCINOMA 26 0.0009
527 NEPHROLITHIASIS 40 0.0009
528 ABNORMAL DREAMS 24 0.0009
529 UROSEPSIS 8 0.0009
530 SHOCK HAEMORRHAGIC 7 0.0009
531 SINUS TACHYCARDIA 12 0.0008
532 EOSINOPHIL COUNT INCREASED 7 0.0008
533 MYOCLONUS 10 0.0008
534 ODYNOPHAGIA 5 0.0008
535 HYPERLIPIDAEMIA 10 0.0008
536 POLYNEUROPATHY 10 0.0008
537 HUMERUS FRACTURE 4 0.0008
538 CARDIOVASCULAR DISORDER 21 0.0008
539 NEURALGIA 20 0.0008
540 BODY TEMPERATURE DECREASED 8 0.0008
541 INFLAMMATORY MARKER INCREASED 4 0.0008
542 CHOLANGITIS 5 0.0008
543 ABDOMINAL TENDERNESS 4 0.0008
544 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
545 HYPERKALAEMIA 28 0.0008
546 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
547 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
548 DISEASE RECURRENCE 37 0.0008
549 ANOREXIA 10 0.0008
550 HEPATOCELLULAR INJURY 11 0.0008
551 PRESCRIBED OVERDOSE 15 0.0008
552 SKELETAL INJURY 8 0.0008
553 GASTROINTESTINAL CARCINOMA 7 0.0008
554 VENTRICULAR EXTRASYSTOLES 8 0.0008
555 HYPERTHYROIDISM 11 0.0008
556 HALLUCINATION, AUDITORY 12 0.0008
557 ENCEPHALOPATHY 18 0.0007
558 ESCHERICHIA INFECTION 6 0.0007
559 NEPHROTIC SYNDROME 5 0.0007
560 DEPRESSED MOOD 38 0.0007
561 LEUKOCYTOSIS 13 0.0007
562 BLOOD CALCIUM DECREASED 8 0.0007
563 DIABETIC KETOACIDOSIS 17 0.0007
564 RENAL INJURY 21 0.0007
565 DYSPHAGIA 67 0.0007
566 DIALYSIS 10 0.0007
567 SKIN HYPERPIGMENTATION 6 0.0007
568 ABSCESS 11 0.0007
569 BLOOD URINE PRESENT 13 0.0007
570 ORAL DISORDER 5 0.0007
571 PURPURA 6 0.0007
572 BRADYKINESIA 4 0.0007
573 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
574 ATAXIA 8 0.0007
575 VERTIGO 41 0.0007
576 PHOTOSENSITIVITY REACTION 11 0.0007
577 PEMPHIGOID 5 0.0007
578 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
579 HIDRADENITIS 6 0.0007
580 ANGIOEDEMA 29 0.0007
581 CANDIDA INFECTION 11 0.0007
582 RENAL FAILURE CHRONIC 5 0.0006
583 GRAND MAL CONVULSION 6 0.0006
584 MUCOSAL INFLAMMATION 17 0.0006
585 LYMPHOMA 10 0.0006
586 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
587 PELVIC FRACTURE 5 0.0006
588 PRODUCT USE IN UNAPPROVED INDICATION 158 0.0006
589 STAPHYLOCOCCAL INFECTION 21 0.0006
590 BLOOD SODIUM DECREASED 12 0.0006
591 NEUTROPENIA 86 0.0006
592 PNEUMOTHORAX 10 0.0006
593 EOSINOPHILIA 11 0.0006
594 HYPOXIA 22 0.0006
595 ERECTILE DYSFUNCTION 16 0.0006
596 CHROMATURIA 14 0.0006
597 REBOUND EFFECT 7 0.0006
598 RASH GENERALISED 16 0.0006
599 TOXICITY TO VARIOUS AGENTS 104 0.0006
600 LIVER INJURY 15 0.0006
601 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
602 HYPOTONIA 6 0.0006
603 LEUKOPENIA 30 0.0006
604 BACTERAEMIA 7 0.0006
605 DRUG ABUSE 49 0.0006
606 DRUG TOXICITY 8 0.0006
607 ECCHYMOSIS 4 0.0006
608 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
609 RENAL DISORDER 27 0.0006
610 COGNITIVE DISORDER 27 0.0006
611 ACUTE MYELOID LEUKAEMIA 9 0.0006
612 NOCTURIA 7 0.0006
613 THROMBOCYTOPENIA 64 0.0006
614 SKIN DISORDER 19 0.0006
615 DUODENAL ULCER 4 0.0006
616 PYREXIA 196 0.0006
617 LYMPHOPENIA 8 0.0006
618 ILEUS 7 0.0006
619 LOSS OF LIBIDO 5 0.0006
620 MYELODYSPLASTIC SYNDROME 8 0.0006
621 RESPIRATORY FAILURE 40 0.0005
622 FEBRILE NEUTROPENIA 36 0.0005
623 LABORATORY TEST ABNORMAL 16 0.0005
624 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
625 VENTRICULAR FIBRILLATION 6 0.0005
626 PERSONALITY CHANGE 5 0.0005
627 AGRANULOCYTOSIS 10 0.0005
628 SEPSIS 60 0.0005
629 INTESTINAL PERFORATION 6 0.0005
630 PHOTOPHOBIA 10 0.0005
631 HYPOCALCAEMIA 10 0.0005
632 HYPERTHERMIA 4 0.0005
633 SHOCK 12 0.0005
634 ATELECTASIS 5 0.0005
635 LUNG INFECTION 8 0.0005
636 THERAPY NON-RESPONDER 23 0.0005
637 SUICIDE ATTEMPT 31 0.0005
638 ADVERSE EVENT 47 0.0005
639 HIP FRACTURE 16 0.0005
640 CYTOPENIA 6 0.0005
641 MUSCLE SPASTICITY 6 0.0005
642 CARDIOMEGALY 6 0.0005
643 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
644 RASH PRURITIC 26 0.0005
645 POLLAKIURIA 20 0.0005
646 DYSARTHRIA 18 0.0005
647 DERMATITIS ALLERGIC 6 0.0005
648 HYPOKALAEMIA 22 0.0005
649 MUSCLE ATROPHY 6 0.0005
650 SUDDEN DEATH 5 0.0005
651 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
652 NIGHT SWEATS 15 0.0005
653 ANURIA 4 0.0005
654 DYSURIA 17 0.0005
655 SEPTIC SHOCK 20 0.0005
656 SEDATION 12 0.0005
657 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
658 GASTRITIS 12 0.0005
659 IMMUNE SYSTEM DISORDER 6 0.0005
660 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
661 FEMUR FRACTURE 14 0.0005
662 EJECTION FRACTION DECREASED 7 0.0004
663 PLEURAL EFFUSION 27 0.0004
664 SENSORY DISTURBANCE 7 0.0004
665 RESPIRATORY ARREST 12 0.0004
666 HAEMATEMESIS 11 0.0004
667 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
668 PAIN 264 0.0004
669 RASH MACULAR 15 0.0004
670 LIVER DISORDER 19 0.0004
671 OSTEOARTHRITIS 18 0.0004
672 IMPAIRED WORK ABILITY 9 0.0004
673 WRIST FRACTURE 5 0.0004
674 AFFECT LABILITY 4 0.0004
675 LIVER FUNCTION TEST ABNORMAL 12 0.0004
676 DIZZINESS POSTURAL 4 0.0004
677 NO THERAPEUTIC RESPONSE 5 0.0004
678 HAEMATURIA 14 0.0004
679 CONFUSIONAL STATE 66 0.0004
680 CARDIOMYOPATHY 6 0.0004
681 HAEMATOCRIT DECREASED 8 0.0004
682 BLOOD POTASSIUM DECREASED 12 0.0004
683 MENTAL STATUS CHANGES 11 0.0004
684 HYPOTHERMIA 4 0.0004
685 HIP ARTHROPLASTY 6 0.0004
686 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
687 MYELOSUPPRESSION 14 0.0004
688 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
689 HIATUS HERNIA 5 0.0004
690 BONE DISORDER 7 0.0004
691 NODULE 5 0.0004
692 HAEMOGLOBIN DECREASED 39 0.0004
693 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
694 NEUROPATHY PERIPHERAL 36 0.0004
695 CONDITION AGGRAVATED 115 0.0004
696 COMA 18 0.0004
697 CONJUNCTIVITIS 7 0.0004
698 BONE PAIN 22 0.0004
699 BACTERIAL INFECTION 7 0.0004
700 HEPATIC FUNCTION ABNORMAL 14 0.0004
701 DEHYDRATION 50 0.0004
702 BLOOD POTASSIUM INCREASED 6 0.0004
703 UVEITIS 5 0.0004
704 SLEEP DISORDER 26 0.0004
705 SLEEP APNOEA SYNDROME 7 0.0004
706 HEPATIC ENZYME INCREASED 25 0.0004
707 MANIA 6 0.0004
708 LOWER LIMB FRACTURE 7 0.0004
709 HYPOTENSION 73 0.0004
710 MELAENA 8 0.0004
711 DRUG INTOLERANCE 35 0.0004
712 MOBILITY DECREASED 26 0.0004
713 DYSTONIA 7 0.0004
714 DISORIENTATION 14 0.0004
715 CARDIAC ARREST 29 0.0004
716 SCAR 6 0.0004
717 CYTOKINE RELEASE SYNDROME 7 0.0003
718 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
719 ELECTROLYTE IMBALANCE 4 0.0003
720 MYOCARDIAL INFARCTION 60 0.0003
721 INTENTIONAL OVERDOSE 22 0.0003
722 MOVEMENT DISORDER 11 0.0003
723 DYSSTASIA 10 0.0003
724 MYALGIA 58 0.0003
725 AGITATION 25 0.0003
726 BLISTER 19 0.0003
727 HYPONATRAEMIA 19 0.0003
728 PULMONARY EMBOLISM 32 0.0003
729 THIRST 6 0.0003
730 PULMONARY MASS 5 0.0003
731 CHOLELITHIASIS 11 0.0003
732 GASTROINTESTINAL DISORDER 30 0.0003
733 TOOTHACHE 6 0.0003
734 BURSITIS 4 0.0003
735 HYPERGLYCAEMIA 12 0.0003
736 PANIC ATTACK 12 0.0003
737 DIABETES MELLITUS 25 0.0003
738 RESTLESSNESS 12 0.0003
739 TACHYCARDIA 29 0.0003
740 LIVER FUNCTION TEST INCREASED 7 0.0003
741 GENERALISED OEDEMA 4 0.0003
742 DELUSION 5 0.0003
743 OFF LABEL USE 279 0.0003
744 CARDIO-RESPIRATORY ARREST 13 0.0003
745 MUSCLE TIGHTNESS 5 0.0003
746 VOMITING 145 0.0003
747 DIPLOPIA 8 0.0003
748 SWELLING FACE 20 0.0003
749 HYPERTENSION 65 0.0003
750 SEIZURE 35 0.0003
751 PANCREATITIS 16 0.0003
752 C-REACTIVE PROTEIN INCREASED 11 0.0003
753 UPPER LIMB FRACTURE 6 0.0003
754 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
755 GENERAL PHYSICAL HEALTH DETERIORATION 34 0.0003
756 GAIT DISTURBANCE 56 0.0003
757 ABDOMINAL PAIN 68 0.0003
758 RESPIRATORY DISTRESS 8 0.0003
759 INSOMNIA 77 0.0003
760 CEREBRAL INFARCTION 7 0.0003
761 MASS 4 0.0003
762 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
763 DIARRHOEA 180 0.0003
764 LETHARGY 16 0.0003
765 ABNORMAL BEHAVIOUR 11 0.0003
766 ABDOMINAL PAIN LOWER 7 0.0003
767 VAGINAL HAEMORRHAGE 12 0.0003
768 OSTEOMYELITIS 5 0.0003
769 FLUID OVERLOAD 4 0.0003
770 DYSPEPSIA 27 0.0003
771 ASTHENIA 103 0.0003
772 EYE DISORDER 9 0.0003
773 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
774 SKIN EXFOLIATION 23 0.0003
775 LIP SWELLING 9 0.0003
776 HYPERSENSITIVITY 50 0.0003
777 HYPOGLYCAEMIA 13 0.0003
778 ORAL PAIN 6 0.0003
779 RASH PAPULAR 6 0.0003
780 HAEMORRHAGE INTRACRANIAL 4 0.0003
781 TYPE 2 DIABETES MELLITUS 9 0.0003
782 PNEUMONIA 86 0.0003
783 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
784 DEEP VEIN THROMBOSIS 17 0.0003
785 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
786 DELIRIUM 9 0.0003
787 PALLOR 7 0.0003
788 EAR PAIN 5 0.0003
789 MOOD ALTERED 7 0.0003
790 ORAL HERPES 5 0.0003
791 HALLUCINATION 19 0.0003
792 DRUG INEFFECTIVE 331 0.0003
793 INTERSTITIAL LUNG DISEASE 12 0.0002
794 MENTAL IMPAIRMENT 6 0.0002
795 BODY TEMPERATURE INCREASED 5 0.0002
796 HERPES ZOSTER 14 0.0002
797 WEIGHT DECREASED 68 0.0002
798 CHEST PAIN 45 0.0002
799 DISTURBANCE IN ATTENTION 13 0.0002
800 OEDEMA 13 0.0002
801 COVID-19 42 0.0002
802 GAIT INABILITY 8 0.0002
803 DERMATITIS 5 0.0002
804 MUSCULAR WEAKNESS 27 0.0002
805 GASTRIC DISORDER 8 0.0002
806 DECREASED APPETITE 54 0.0002
807 SKIN ULCER 6 0.0002
808 APHASIA 7 0.0002
809 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
810 RESPIRATORY TRACT INFECTION 6 0.0002
811 DISEASE PROGRESSION 27 0.0002
812 DEATH 195 0.0002
813 GYNAECOMASTIA 7 0.0002
814 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
815 EAR INFECTION 6 0.0002
816 WEIGHT INCREASED 50 0.0002
817 FEAR 6 0.0002
818 GOUT 4 0.0002
819 FATIGUE 173 0.0002
820 PALPITATIONS 26 0.0002
821 INFECTION 32 0.0002
822 AGGRESSION 11 0.0002
823 DEMENTIA 6 0.0002
824 DYSPNOEA 121 0.0002
825 CHILLS 25 0.0002
826 INTESTINAL OBSTRUCTION 8 0.0002
827 VISUAL ACUITY REDUCED 7 0.0002
828 GASTRIC ULCER 4 0.0002
829 SYNCOPE 21 0.0002
830 RED BLOOD CELL COUNT DECREASED 6 0.0002
831 NEOPLASM MALIGNANT 14 0.0002
832 RECTAL HAEMORRHAGE 9 0.0002
833 INCREASED APPETITE 4 0.0002
834 ACUTE RESPIRATORY FAILURE 4 0.0002
835 MENTAL DISORDER 9 0.0002
836 OEDEMA PERIPHERAL 25 0.0002
837 CHOKING 4 0.0002
838 OVERDOSE 44 0.0002
839 NIGHTMARE 7 0.0002
840 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
841 HAEMORRHAGE 21 0.0002
842 FULL BLOOD COUNT DECREASED 4 0.0002
843 MEDICATION ERROR 11 0.0002
844 RASH 86 0.0002
845 DYSKINESIA 8 0.0002
846 BLINDNESS 8 0.0002
847 EPILEPSY 6 0.0002
848 HYPOPHAGIA 5 0.0002
849 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
850 NAUSEA 154 0.0002
851 INFLAMMATION 10 0.0002
852 UNRESPONSIVE TO STIMULI 5 0.0002
853 HAEMATOMA 5 0.0002
854 CONVULSION 11 0.0002
855 ROAD TRAFFIC ACCIDENT 8 0.0002
856 DEAFNESS 5 0.0002
857 PRODUCTIVE COUGH 9 0.0002
858 RASH ERYTHEMATOUS 9 0.0002
859 JOINT INJURY 4 0.0002
860 DYSPNOEA EXERTIONAL 7 0.0002
861 THROAT TIGHTNESS 5 0.0002
862 IRRITABILITY 11 0.0002
863 COUGH 51 0.0002
864 THERAPEUTIC RESPONSE DECREASED 11 0.0002
865 BLOOD PRESSURE DECREASED 12 0.0002
866 FEELING COLD 5 0.0002
867 PLATELET COUNT DECREASED 19 0.0002
868 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
869 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
870 CARDIAC FAILURE 14 0.0002
871 TINNITUS 8 0.0002
872 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
873 MUSCULOSKELETAL PAIN 9 0.0002
874 PARAESTHESIA 27 0.0002
875 BLOOD CHOLESTEROL INCREASED 8 0.0002
876 DYSPHONIA 10 0.0002
877 SWELLING 16 0.0002
878 URINARY TRACT INFECTION 29 0.0002
879 AMNESIA 11 0.0002
880 CEREBRAL HAEMORRHAGE 6 0.0002
881 ADVERSE DRUG REACTION 15 0.0002
882 BACK PAIN 38 0.0002
883 HEADACHE 101 0.0002
884 EPISTAXIS 12 0.0002
885 PRODUCT USE ISSUE 30 0.0002
886 DRUG WITHDRAWAL SYNDROME 14 0.0002
887 PRURITUS 61 0.0002
888 INJURY 11 0.0002
889 HOSPITALISATION 24 0.0002
890 HYPERHIDROSIS 20 0.0002
891 ANAPHYLACTIC SHOCK 4 0.0002
892 HYPOAESTHESIA 23 0.0002
893 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
894 SKIN IRRITATION 7 0.0002
895 SPEECH DISORDER 8 0.0002
896 IMPAIRED HEALING 5 0.0002
897 BRADYCARDIA 8 0.0002
898 ARTHRALGIA 62 0.0001
899 FEELING HOT 9 0.0001
900 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
901 HAEMOPTYSIS 4 0.0001
902 NECK PAIN 8 0.0001
903 ANGINA PECTORIS 4 0.0001
904 THERAPY CESSATION 7 0.0001
905 LOSS OF CONSCIOUSNESS 17 0.0001
906 ABDOMINAL DISCOMFORT 22 0.0001
907 OROPHARYNGEAL PAIN 12 0.0001
908 CONSTIPATION 28 0.0001
909 CARDIAC DISORDER 12 0.0001
910 ALOPECIA 25 0.0001
911 ARTHRITIS 10 0.0001
912 ARRHYTHMIA 6 0.0001
913 TREMOR 21 0.0001
914 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
915 ABDOMINAL PAIN UPPER 26 0.0001
916 MIGRAINE 12 0.0001
917 MUSCULOSKELETAL STIFFNESS 11 0.0001
918 RHINORRHOEA 8 0.0001
919 MALAISE 54 0.0001
920 NEUTROPHIL COUNT DECREASED 5 0.0001
921 LUNG DISORDER 6 0.0001
922 DIZZINESS 60 0.0001
923 SOMNOLENCE 24 0.0001
924 WITHDRAWAL SYNDROME 5 0.0001
925 ANGER 4 0.0001
926 SINUSITIS 12 0.0001
927 ECZEMA 6 0.0001
928 HEART RATE DECREASED 4 0.0001
929 CARDIAC FAILURE CONGESTIVE 9 0.0001
930 THROMBOSIS 9 0.0001
931 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
932 SKIN DISCOLOURATION 5 0.0001
933 FALL 36 0.0001
934 BRONCHITIS 8 0.0001
935 COMPLETED SUICIDE 9 0.0001
936 CHEST DISCOMFORT 11 0.0001
937 CEREBROVASCULAR ACCIDENT 18 0.0001
938 HOT FLUSH 8 0.0001
939 UNEVALUABLE EVENT 8 0.0001
940 ACNE 8 0.0001
941 CONTUSION 10 0.0001
942 PERIPHERAL SWELLING 16 0.0001
943 MUSCLE SPASMS 19 0.0001
944 ERYTHEMA 21 0.0001
945 URTICARIA 17 0.0001
946 NO ADVERSE EVENT 18 0.0001
947 CELLULITIS 5 0.0001
948 BLOOD PRESSURE INCREASED 15 0.0001
949 LUNG NEOPLASM MALIGNANT 4 0.0001
950 INFLUENZA LIKE ILLNESS 8 0.0001
951 ABDOMINAL DISTENSION 10 0.0001
952 ATRIAL FIBRILLATION 9 0.0001
953 INTENTIONAL PRODUCT MISUSE 8 0.0001
954 ANAPHYLACTIC REACTION 5 0.0001
955 ARTHROPATHY 5 0.0001
956 OXYGEN SATURATION DECREASED 5 0.0001
957 PAIN IN EXTREMITY 26 0.0001
958 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
959 BLOOD GLUCOSE DECREASED 4 0.0001
960 DISCOMFORT 5 0.0001
961 BALANCE DISORDER 7 0.0001
962 ASTHMA 9 0.0001
963 BLOOD GLUCOSE INCREASED 15 0.0001
964 PRODUCT DOSE OMISSION 5 0.0001
965 DRY MOUTH 6 0.0001
966 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
967 MEMORY IMPAIRMENT 10 0.0001
968 HEART RATE INCREASED 7 0.0001
969 NASOPHARYNGITIS 13 0.0001
970 DRY SKIN 9 0.0001
971 DYSGEUSIA 5 0.0001
972 CATARACT 4 0.0001
973 PSORIASIS 8 0.0001
974 FLUSHING 6 0.0001
975 FEELING ABNORMAL 14 0.0001
976 INJECTION SITE REACTION 4 0.0001
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
978 INFLUENZA 6 0.0001
979 VISION BLURRED 7 0.0001
980 DRUG DEPENDENCE 8 0.0000
981 PRODUCT DOSE OMISSION ISSUE 13 0.0000
982 INCORRECT DOSE ADMINISTERED 10 0.0000
983 JOINT SWELLING 5 0.0000
984 VISUAL IMPAIRMENT 5 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
986 ILLNESS 4 0.0000
987 DRUG DOSE OMISSION 5 0.0000